Micro Emerging Active

Profluent partners with Lilly for genetic medicines

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Apr 28, 2026
Profluent Inks Up To $2.25 Bln Deal With Lilly For Genetic Medicines Neutral

Related Articles

Profluent Inks Up To $2.25 Bln Deal With Lilly For Genetic Medicines

Nasdaq · Apr 28, 2026
Mixed

Timeline

Last UpdatedApr 28, 2026